The cost of bringing a new drug to market is over $2 billion, by some estimates. This covers the R&D, clinical trial testing and regulatory approval costs of the drug that makes it through the whole process, and also the same costs of the 9 drugs that don’t make it, for each drug that does.Continue reading “Industry Spotlight – Pharma”
Daily Archives: May 13, 2019
Statistically Significant – But Not True
If you are looking for the Feature Engineering blog post, you can find it here: https://www.statistics.com/feature-engineering-data-prep-still-needed/ In 2015, at an Alzheimer’s conference, Biogen researchers presented dramatic brain scans showing that the antibody aducanumab effectively cleared out plaque in the brain, plaque that was associated with Alzheimer’s disease. Their study involved 166 patients in a randomized,Continue reading “Statistically Significant – But Not True”